Fingerprint
Dive into the research topics of 'Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
N. M. Flynn, D. N. Forthal, C. D. Harro, F. N. Judson, K. H. Mayer, M. F. Para, Marc Gurwith
Research output: Contribution to journal › Article › peer-review
709
Scopus
citations